Pharmacotherapeutic consequences of recent advances in hemodialysis therapy.
Matzke
G R
GR
Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, PA 15261.
D058186:Acute Kidney Injury / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D004358:Drug Therapy / Q000639:trends*; D004921:Erythropoietin / Q000378:metabolism; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010599:Pharmacokinetics; D011994:Recombinant Proteins / Q000378:metabolism; D006435:Renal Dialysis / Q000295:instrumentation / Q000639:trends*
D000900:Anti-Bacterial Agents; D011994:Recombinant Proteins; D004921:Erythropoietin